Related Experiment Video

Updated: May 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumoparotitis: a case report

Angela E McGreevy1, Anna M O'Kane, David McCaul

  • 1ENT Department, Craigavon Area Hospital, Portadown, Northern Ireland. angelamcgreevy@doctors.org.uk

Head & Neck
|March 21, 2012
PubMed
Abstract

Insights

Pneumoparotid, a rare cause of parotid enlargement due to air insufflation, can lead to chronic infection. Surgical gland excision effectively resolved symptoms in a chronic case.

Area of Science:

  • Otorhinolaryngology
  • Surgical Pathology

Background:

  • Pneumoparotid, characterized by parotid gland enlargement, results from retrograde air insufflation through Stensen's duct.
  • Conservative management is typical for acute cases, often leading to a short clinical course.

Observation:

  • A 48-year-old male presented with chronic painful facial swelling and recurrent infections.
  • Clinical findings included parotid swelling, surgical emphysema, and a dilated Stensen's duct.
  • CT confirmed pneumoparotitis with cystic changes and intraparotid duct dilation.

Findings:

  • Chronic pneumoparotitis can develop from repeated retrograde air and saliva movement, causing infection and sialectasis.
  • Surgical excision of the parotid gland led to symptom resolution in this chronic case.

Implications:

  • Early identification and management of the causative insult are crucial for preventing chronic sequelae.
  • Glandular excision is a viable treatment for refractory chronic pneumoparotitis.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: